Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2. This evidence concerns the gene FGFR2 and nasopharyngeal carcinoma.